Matthew Cooper

The Preeclampsia Foundation is an organization that aims to address the significant unmet need for an effective treatment for preeclampsia, a common and severe complication of pregnancy characterized by high blood pressure and multiple organ failure. Preeclampsia affects between 3% and 5% of all pregnancies in the US and is responsible for approximately 20% of all preterm births. It can lead to a range of complications for both the mother and the baby, including multi-organ damage, seizures, and premature birth. Currently, delivery of the baby is the only definitive cure for preeclampsia. The signs and symptoms of preeclampsia can vary and include high blood pressure, acute kidney injury, swelling in the hands and face, severe headaches, vision changes, and abdominal pain. Treatment may include close monitoring of blood pressure and urine protein levels, bed rest, and medication to lower blood pressure.

Avails Medical, Inc. is an in-vitro diagnostics company. The company was founded by Oren Knopfmacher, Meike Herget, Naama Stauber, Robert Fisher, and Nancy Isaac in 2013 and is headquartered in Menlo Park, CA.

Neoseq Ltd. develops and provides healthcare solutions. The company is headquartered in San Diego, CA.

Enumera Molecular, Inc. is a life science tools company based in Ann Arbor, MI. The company has developed a scalable biomolecule assessment platform that enables lower cost and rapid clinical liquid biopsy tests. The company was founded in 2022 by Matthew Cooper with the mission of transforming the field of clinical molecular testing to a simpler, more actionable tool for physicians to benefit patient care.

Carmenta Bioscience, Inc. provides biotechnology services. It offers technology that medical need in maternal and fetal health. The company was founded by Matthew Cooper, Atul J. Butte, and Bruce Ling in 2012 and is headquartered Palo Alto, CA.

Syapse, Inc. develops software solutions that enable healthcare providers to deploy precision medicine programs. Its medical platform is used to integrate complex genomic and clinical data to provide clinicians with actionable insights at point of care, enabling diagnosis, treatment, and outcomes tracking. The firm offers a suite of clinical applications built on the Syapse Precision Medicine Platform and designed to help healthcare providers implement and scale precision medicine at the point of care. The company was founded by Tony Loeser, Glenn S. Winokur, and Jonathan Hirsch in 2008 and is headquartered in San Francisco, CA.

Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.

Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.